We have demonstrated that compared to the NC group, there was a decreased level of Aβ1–42 and a lower Aβ1–42/Aβ1–40 ratio, as well as an elevated level of Aβ1–40, and P-tau and a higher P-tau/T-tau ratio in the AD and AC groups. The gene discussed is MAPT; the disease is Alzheimer disease.